13F reference period
n/a
Security Snapshot
BioNexus Gene Lab Corp - COMMON STOCK, NO PAR VALUE (BGLC) Institutional Ownership
CUSIP: 090628306
13F Institutional Holders and Ownership History from Q2 2025 to Q2 2026
Institutions Reporting
Shares (Excl. Options)
n/a
Price
$1.49
The headline uses the Q3 2026 reference period after its reporting deadline. Available reports may still be incomplete or amended.
Save this security page for your next review
Watchlists follow companies and investors, across their share classes. Bookmark this page to revisit this specific CUSIP and its quarterly holders. If you create an account from here, we will bring you back after verification.
- Security type / class
- Equity / COMMON STOCK, NO PAR VALUE
- Symbol
- BGLC on Nasdaq
- Shares outstanding
- 2,927,828
- SEC-reported price per share
- $1.49
13F Shares, Excluding Options vs Price
13F Value, Excluding Options
Total Investors
Filing notes and source
Key facts
- BGLC - BioNexus Gene Lab Corp - COMMON STOCK, NO PAR VALUE is tracked under CUSIP 090628306.
- 13F reference-period holder data is not available.
- 2 significant owners is listed from Schedule 13D/13G reporting.
Change
- Holder data for the Q3 2026 reference period is not available.
- Available periods remain in the history table; they do not substitute for the headline period.
Research use
- You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
- 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.
Evidence
Source: SEC Schedule 13D/G
Open SEC evidence
Ownership context comes from Schedule 13D/G and available holder history for this CUSIP.
Security key
090628306
13F reference period
n/a
13F holders
13D/G owners
2
CIK / CUSIP context first
BGLC full holder history
BioNexus Gene Lab Corp SEC filings
BioNexus Gene Lab Corp company facts
BioNexus Gene Lab Corp insider transactions
Broader feeds
Recent Quarterly Holder Reports
Open recent reporting periods for CUSIP 090628306:
13D/G owners
Significant owners
Large-stake holder rows connected to Schedule 13D/G evidence.
Rows
2
Security
BGLC
| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| FIDELION DIAGNOSTICS PTE. LTD. | 13% | $584,570 | 392,329 | Fidelion Diagnostics Pte. Ltd. | 28 Nov 2025 | |||
| Tan Lee Su-Leng | 12% | $677,418 | 338,709 | Tan Lee Su-Leng | 13 Aug 2026 |
Quarter history
Institutional holders across reporting periods
Holder count, reported shares/value, and median price by quarter.
Periods
5
Headline period
n/a
Rows shown
1-5 of 5